SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: bentway who wrote (712051)4/26/2013 12:53:13 PM
From: longnshort  Respond to of 1574854
 
hey they are just soaking the 1%ers you should be happy

college tuition is high also don't see you bytching about that



To: bentway who wrote (712051)4/26/2013 2:38:49 PM
From: Tenchusatsu  Read Replies (2) | Respond to of 1574854
 
Bentway, from the article,
More than 100 cancer specialists from more than 15 countries are joining together to call for lower drug prices, suggesting that the current prices—which can range as high as $138,000 a year—are unconscionably high, and could be seen as profiteering.
That's pretty hypocritical coming from oncologists, who typically make about $300K/year.

Tenchusatsu


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News